Article Versions Notes

Heredia-Soto V, Gutiérrez-Sainz L, Ghanem I, Guerra L, Palacios E, de Uribe M, Trilla-Fuertes L, de Miguel M, Cejas P, Medina L, et al. The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma. Biomedicines. 2023; 11(2):252. https://doi.org/10.3390/biomedicines11020252

Heredia-Soto, Victoria, Laura Gutiérrez-Sainz, Ismael Ghanem, Laura Guerra, Elena Palacios, Marta de Uribe, Lucía Trilla-Fuertes, María de Miguel, Paloma Cejas, Laura Medina, and et al. 2023. "The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma" Biomedicines 11, no. 2: 252. https://doi.org/10.3390/biomedicines11020252

Heredia-Soto, V., Gutiérrez-Sainz, L., Ghanem, I., Guerra, L., Palacios, E., de Uribe, M., Trilla-Fuertes, L., de Miguel, M., Cejas, P., Medina, L., Calderón, J. M., Viñal, D., Mendiola, M., & Feliu, J. (2023). The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma. Biomedicines, 11(2), 252. https://doi.org/10.3390/biomedicines11020252